1. Home
  2. VRAR vs EVOK Comparison

VRAR vs EVOK Comparison

Compare VRAR & EVOK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo The Glimpse Group Inc.

VRAR

The Glimpse Group Inc.

HOLD

Current Price

$0.94

Market Cap

21.9M

Sector

Technology

ML Signal

HOLD

Logo Evoke Pharma Inc.

EVOK

Evoke Pharma Inc.

HOLD

Current Price

$10.99

Market Cap

18.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VRAR
EVOK
Founded
2016
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Retail: Computer Software & Peripheral Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
21.9M
18.4M
IPO Year
2021
2013

Fundamental Metrics

Financial Performance
Metric
VRAR
EVOK
Price
$0.94
$10.99
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$2.62
N/A
AVG Volume (30 Days)
105.4K
30.8K
Earning Date
11-13-2025
11-13-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$9,488,209.00
$14,424,652.00
Revenue This Year
N/A
$58.96
Revenue Next Year
$72.00
$57.99
P/E Ratio
N/A
N/A
Revenue Growth
16.60
67.40
52 Week Low
$0.89
$1.94
52 Week High
$7.00
$11.00

Technical Indicators

Market Signals
Indicator
VRAR
EVOK
Relative Strength Index (RSI) 32.01 85.30
Support Level $1.03 $10.66
Resistance Level $1.16 $10.99
Average True Range (ATR) 0.09 0.04
MACD -0.00 -0.18
Stochastic Oscillator 2.52 100.00

Price Performance

Historical Comparison
VRAR
EVOK

About VRAR The Glimpse Group Inc.

The Glimpse Group Inc is a diversified immersive technology platform company, focused on providing enterprise solutions in virtual reality (VR), augmented reality (AR), and spatial computing. The company operates multiple subsidiaries that develop VR and AR software and services across various industries, including corporate training, education, healthcare, government, defense, marketing, retail, and financial services. It also offers AI-driven spatial computing platforms that support simulations, social VR, behavioral health, and corporate events. The Company reports its revenues in three categories: Software Services, Software License and Software-as-a-Service (SaaS), and Royalty Income, with the majority being from the Software Services category.

About EVOK Evoke Pharma Inc.

Evoke Pharma Inc is a specialty pharmaceutical company focused on the development and commercialization of drugs to treat gastrointestinal, or GI, disorders, and diseases. The company's product Gimoti is an investigational metoclopramide nasal spray for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women. Gimoti is a novel nasal spray formulation of metoclopramide designed to provide systemic delivery of the molecule through the nasal mucosa.

Share on Social Networks: